Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome

키워드

참고문헌 (37)

1. Teede H, "Polycystic ovary syndrome : a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan", BMC Med, 8, pp.41~ (2010)
2. Azziz R, "Polycystic ovary syndrome", Nat Rev Dis Primers, 2, pp.16057~ (2016)
3. Arroyo A, "Inappropriate gonadotropin secretion in polycystic ovary syndrome : influence of adiposity", J Clin Endocrinol Metab, 82, pp.3728~3733 (1997)
4. Carmina E, "Polycystic ovary syndrome(PCOS) : arguably the most common endocrinopathy is associated with significant morbidity in women", J Clin Endocrinol Metab, 84, pp.1897~1899 (1999)
5. The Rotterdam ESHRE, "ASRM-Sponsored PCOS Consensus Workshop Group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
6. Weenen C, "Anti-Müllerian hormone expression pattern in the human ovary : potential implications for initial and cyclic follicle recruitment", Mol Hum Reprod, 10, pp.77~83 (2004)
7. Durlinger AL, "Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary", Endocrinology, 143, pp.1076~1084 (2002)
8. Durlinger AL, "Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary", Endocrinology, 142, pp.4891~4899 (2001)
9. 이정렬, "여성 생식에서 Anti-Müllerian Hormone의 역할", Obstetrics & Gynecology Science, 52(3), pp.285~300 (2009), 대한산부인과학회
10. Teede HJ, "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome", Hum Reprod, 33, pp.1602~1618 (2018)
11. Bhattacharya SM, "Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome", Int J Gynaecol Obstet, 132, pp.210~213 (2016)
12. Chung JP, "A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome", J Pediatr Adolesc Gynecol, 27, pp.166~171 (2014)
13. Kriplani A, "Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome", Contraception, 82, pp.139~146 (2010)
14. Ozdemir S, "Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome", Int J Gynaecol Obstet, 103, pp.44~49 (2008)
15. Kim JJ, "Assessment of hirsutism among Korean women : results of a randomly selected sample of women seeking pre-employment physical check-up", Hum Reprod, 26, pp.214~220 (2011)
16. Chae SJ, "Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women", Hum Reprod, 23, pp.1924~1931 (2008)
17. Balen AH, "Ultrasound assessment of the polycystic ovary : international consensus definitions", Hum Reprod Update, 9, pp.505~514 (2003)
18. Pigny P, "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome : relationship to the ovarian follicle excess and to the follicular arrest", J Clin Endocrinol Metab, 88, pp.5957~5962 (2003)
19. Mes-Krowinkel MG, "Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients", Fertil Steril, 101, pp.1757~1965.e1 (2014)
20. Ozay AC, "Different effects of myoinositol plus folic acid versus combined oral treatment on androgen levels in PCOS women", Int J Endocrinol, 2016, pp.3206872~ (2016)
21. Plouvier P, "Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?", Gynecol Endocrinol, 32, pp.612~616 (2016)
22. Fábregues F, "The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age", Gynecol Endocrinol, 27, pp.216~224 (2011)
23. Dursun F, "Assessment of anti-Müllerian hormone level in management of adolescents with polycystic ovary syndrome", J Clin Res Pediatr Endocrinol, 8, pp.55~60 (2016)
24. Panidis D, "The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia", Gynecol Endocrinol, 27, pp.587~592 (2011)
25. Somunkiran A, "Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome", Eur J Obstet Gynecol Reprod Biol, 134, pp.196~201 (2007)
26. Haisenleder DJ, "A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes : evidence for differential regulation of transcription by pulse frequency in vivo", Endocrinology, 128, pp.509~517 (1991)
27. Ehrmann DA, "Polycystic ovary syndrome", N Engl J Med, 352, pp.1223~1236 (2005)
28. 전성욱, "Serum luteinizing hormone level and luteinizing hormone", follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome, 2014, pp.41(2), 86~91[DOI]
29. Chun S, "1-h Postprandial glucose level is related to the serum anti-Müllerian hormone level in women with polycystic ovary syndrome", Gynecol Endocrinol, 31, pp.815~818 (2015)
30. Abdul-Ghani MA, "Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes : results from the Botnia Study", Diabetes Care, 32, pp.281~286 (2009)
31. Nardo LG, "The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome", Hum Reprod, 24, pp.2917~2923 (2009)
32. Skałba P, "Is the plasma anti-Müllerian hormone(AMH)level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?", Eur J Obstet Gynecol Reprod Biol, 158, pp.254~259 (2011)
33. 박찬홍, "Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome", Obstetrics & Gynecology Science, 59(6), pp.498~505 (2016), 대한산부인과학회[DOI]
34. 심아라, "다낭성난소증후군에서 성선자극호르몬 분비 이상과 임상적, 호르몬, 대사적 특성과의 연관성", Obstetrics & Gynecology Science, 54(11), pp.659~665 (2011), 대한산부인과학회
35. Caglar GS, "Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS", Arch Gynecol Obstet, 288, pp.905~910 (2013)
36. Cassar S, "Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins", Clin Endocrinol (Oxf), 81, pp.899~906 (2014)
37. Monash University, "International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome", Monash University, ~ (2018)

관련 논문AI추천